公开(公告)号：US20120258919A1

公开(公告)日：2012-10-11

申请号：US13523438

申请日：2012-06-14

申请人： Fumihito SUGIHARA ,  Naoki INOUE ,  Seiko KOIZUMI ,  Chinfang LIU ,  Hajime TAKASAKI ,  Hisayuki KOBAYASHI ,  Hiroshi MANO ,  Sachie NAKATANI ,  Masahiro WADA

发明人： Fumihito SUGIHARA ,  Naoki INOUE ,  Seiko KOIZUMI ,  Chinfang LIU ,  Hajime TAKASAKI ,  Hisayuki KOBAYASHI ,  Hiroshi MANO ,  Sachie NAKATANI ,  Masahiro WADA

IPC分类号： A61K38/05 ,  A61P17/02 ,  A61P19/10 ,  A61P19/02

CPC分类号： C07K5/06139 ,  A61K38/05 ,  C07K5/06165

摘要： A problem that the present invention is to solve is to provide: a main body of a peptide molecule which is effective for inhibition of various maladies such as osteoporosis, osteoarthritis and pressure ulcer, particularly, a dipeptide which is easy to absorb into a body in an intestine; a collagen peptide which comprises the dipeptide as an essential dipeptide; and a malady inhibitor which comprises the dipeptide as an essential effective component. As a means of solving such a problem, a collagen peptide according to the present invention is characterized by comprising a dipeptide having a structure of Hyp-Gly as an essential dipeptide. A dipeptide according to the present invention is characterized by having a structure of Hyp-Gly. A malady inhibitor according to the present invention is characterized by comprising a dipeptide having a structure of Hyp-Gly as an essential effective component.

摘要翻译： 本发明要解决的问题是提供：对于抑制诸如骨质疏松症，骨关节炎和压力性溃疡等各种疾病的肽分子的主体，特别是容易吸收到体内的二肽 肠 包含二肽作为必需二肽的胶原肽; 以及包含二肽作为基本有效成分的疾病抑制剂。 作为解决上述问题的方法，本发明的胶原肽的特征在于，含有具有Hyp-Gly结构的二肽作为必需二肽的二肽。 根据本发明的二肽的特征在于具有Hyp-Gly的结构。 根据本发明的疾病抑制剂的特征在于包含具有Hyp-Gly结构作为必需有效成分的二肽。